医院再入院率作为卵巢癌手术质量指标的局限性
该回顾性队列研究纳入2004至2013年国家癌症数据库中42931例晚期高级别浆液性卵巢癌手术患者,比较医院30天再入院率与其他质量指标的关系。年手术量31例及以上的医院再入院可能性更高(调整OR 1.25),但90天死亡率更低(调整OR 0.74),指南依从率更高(86% vs 77%),总生存更好(调整HR 0.86)。结论认为30天再入院率不宜作为卵巢癌手术质量的独立衡量指标。
要点
- 年手术量≥31例的医院30天再入院调整OR为1.25,高于年手术量≤10例的医院。
- 年手术量≥31例的医院90天死亡率调整OR为0.74,低于低手术量医院。
- 高手术量医院指南依从率为86%,高于低手术量医院的77%(P<.001)。
核心结论
- 年手术量31例及以上的医院尽管实施更复杂的手术,30天和90天死亡率仍更低,更可能遵循指南-based care,且总生存更高。
研究设计与样本
- 回顾性队列研究,纳入2004至2013年国家癌症数据库中诊断为晚期高级别浆液性癌并接受初始治疗的女性,共42931例符合纳入标准。
主要发现
- 总体非计划30天再入院率为6.36%(95% CI 6.13-6.59)。
- 调整合并症、分期、组织学、社会人口学和治疗因素后,年手术量31例及以上的医院再入院可能性比年手术量10例及以下的医院高24%(调整OR 1.25,95% CI 1.06-1.46)。
- 年手术量31例及以上的医院调整后90天死亡率显著更低(调整OR 0.74,95% CI 0.60-0.91),尽管复杂手术比例更高且指南一致 care 比例更高(86% vs 77%,P<.001)。
- Cox比例风险回归模型中,高手术量医院就医独立预测较低死亡风险(调整HR 0.86,95% CI 0.82-0.90)。
临床怎么用
- 作者认为30天再入院率作为卵巢癌手术质量指标存在局限性,高手术量医院再入院率更高但死亡率更低、指南依从性和生存更好。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate the role of 30-day readmission rate as a quality of care metric in patients undergoing ovarian cancer surgery. METHODS: We performed a retrospective cohort study of women diagnosed between 2004 and 2013 with advanced-stage, high-grade, serous carcinoma who underwent primary treatment. Using the National Cancer Database, we compared the performance of hospital risk-adjusted 30-day readmission rate to other quality of care metrics (risk-adjusted 30- and 90-day mortality, rates of adherence to guideline-based care, and overall survival) within hospitals categorized by yearly case volume (10 or less, 11-20, 21-30, and 31 cases per year or more). RESULTS: A total of 42,931 patients met the inclusion criteria. The overall unplanned 30-day readmission rate was 6.36% (95% CI 6.13-6.59). After adjusting for comorbidity, stage, histology, and sociodemographic and treatment factors, hospitals performing 31 cases per year or more had a 24% higher likelihood of readmission (adjusted odds ratio [OR] 1.25, 95% CI 1.06-1.46) when compared with those performing 10 cases per year or less. However, hospitals performing 31 cases per year or more had a significantly lower risk-adjusted 90-day mortality (adjusted OR 0.74, 95% CI 0.60-0.91) despite higher rates of complex surgical procedures and higher rates of guideline-concordant care delivery (86% vs 77%, P<.001). In the Cox proportional hazards regression model, care at a high-volume hospital was independently predictive of lower hazard of death (adjusted hazard ratio 0.86, 95% CI 0.82-0.90). CONCLUSION: Hospitals with 31 cases per year or more have a lower 30- and 90-day mortality despite performing more complex surgeries, are more likely to be adherent to guideline-based care, and achieved higher overall survival.
引用
- Uppal S, Spencer RJ, Rice LW, et al. Hospital Readmission as a Poor Measure of Quality in Ovarian Cancer Surgery. Obstet Gynecol. 2018. PMID: 29889756. doi:10.1097/AOG.0000000000002693
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。